Physician profile
Jeffrey Glover
NPI 1588639678
$13,333.95
in general payments reported to CMS, 2019-2025
46 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,233 · 2020: $1,453 · 2021: $1,779 · 2022: $1,899 · 2023: $2,200 · 2024: $1,617 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,931 · Education: $38.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,930.88 |
| Education | $38.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,915.57 | 2019-2024 | |
| Amgen INC. | $1,854.32 | 2019-2025 | Evenity, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,611.48 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $918.91 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Allergan, INC. | $762.60 | 2019-2020 | |
| Lilly USA, LLC | $674.34 | 2019-2024 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $654.58 | 2019-2023 | |
| Novo Nordisk INC | $537.13 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $490.63 | 2019-2024 | |
| Exact Sciences Corporation | $320.34 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $298.14 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $273.52 | 2022-2023 | |
| Abbott Laboratories | $267.84 | 2023-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $260.94 | 2019-2021 | |
| Silk Road Medical, INC. | $247.99 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Glover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.